Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-008053
Filing Date
2004-03-15
Accepted
2004-03-15 17:23:41
Documents
10
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2130506z10-k.htm 10-K 502752
3 EXHIBIT 10.30 a2130506zex-10_30.htm EX-10.30 4127
4 EXHIBIT 10.31 a2130506zex-10_31.htm EX-10.31 67358
5 EXHIBIT 10.32 a2130506zex-10_32.htm EX-10.32 69059
6 EXHIBIT 23.1 a2130506zex-23_1.htm EX-23.1 2461
7 EX-23.2 a2130506zex-23_2.htm EX-23.2 5030
8 EXHIBIT 31.1 a2130506zex-31_1.htm EX-31.1 5062
9 EXHIBIT 31.2 a2130506zex-31_2.htm EX-31.2 5070
10 EXHIBIT 32.1 a2130506zex-32_1.htm EX-32.1 2327
11 EXHIBIT 32.2 a2130506zex-32_2.htm EX-32.2 2335
  Complete submission text file 0001047469-04-008053.txt   668222
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12493 | Film No.: 04670569
SIC: 2836 Biological Products, (No Diagnostic Substances)